These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 21082940)
1. Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage. Crowther M; Crowther M Expert Rev Hematol; 2009 Aug; 2(4):357-60. PubMed ID: 21082940 [No Abstract] [Full Text] [Related]
2. [Thrombosis ABC, 5: No prophylaxis without bleeding risk. Safe navigation between Scylla and Charybdis]. Stiefelhagen P MMW Fortschr Med; 1999 Oct; 141(43):42. PubMed ID: 10912121 [No Abstract] [Full Text] [Related]
3. [The value of laboratory diagnosis in thrombolytic therapy]. Ostermann H; Kienast J Internist (Berl); 1992 Apr; 33(4):252-7. PubMed ID: 1612849 [No Abstract] [Full Text] [Related]
4. Guideline on the management of bleeding in patients on antithrombotic agents. Makris M; Van Veen JJ; Tait CR; Mumford AD; Laffan M; Br J Haematol; 2013 Jan; 160(1):35-46. PubMed ID: 23116425 [No Abstract] [Full Text] [Related]
5. [Thrombosis and new antithrombotic agents]. Drouet L; Mahé I; Le Gal G; Righini M; Quéré I Rev Med Interne; 2011 Dec; 32 Suppl 2():S236-40. PubMed ID: 22041519 [No Abstract] [Full Text] [Related]
6. [Perioperative thrombosis prophylaxis - thrombosis or bleeding - that is the question]. Ellger B; Van Aken HK Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Apr; 47(4):240-1. PubMed ID: 22504620 [No Abstract] [Full Text] [Related]
7. [Anticoagulation in thrombolytic therapy: importance and future perspectives]. Harenberg J; Heene DL Z Gesamte Inn Med; 1993; 48(6-7):283-8. PubMed ID: 8333224 [TBL] [Abstract][Full Text] [Related]
9. No risk, no benefit: still true for antithrombotic stroke treatments? Minnerup J; Kleinschnitz C Future Med Chem; 2013 Mar; 5(4):377-9. PubMed ID: 23495684 [No Abstract] [Full Text] [Related]
11. Antithrombotic therapy: new areas to understand efficacy and bleeding. Wisler JW; Becker RC Expert Opin Ther Targets; 2014 Dec; 18(12):1427-34. PubMed ID: 25347453 [TBL] [Abstract][Full Text] [Related]
12. Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome. Van de Werf F Circulation; 2010 Jan; 121(1):5-7. PubMed ID: 20026787 [No Abstract] [Full Text] [Related]
13. [New strategies and perspectives in thrombolytic therapy]. Bode C; Kübler W Internist (Berl); 1992 Apr; 33(4):258-64. PubMed ID: 1612850 [No Abstract] [Full Text] [Related]
14. The Janus face of thromboprophylaxis in patients with high risk for both thrombosis and bleeding during intracranial surgery: report of five exemplary cases. Niemi T; Silvasti-Lundell M; Armstrong E; Hernesniemi J Acta Neurochir (Wien); 2009 Oct; 151(10):1289-94. PubMed ID: 19513580 [TBL] [Abstract][Full Text] [Related]
15. [Complications of anticoagulant and thrombolytic therapy]. Sparacia A; Di Chiara A Minerva Anestesiol; 1981 Mar; 47(3):115-22. PubMed ID: 6454086 [No Abstract] [Full Text] [Related]
16. [Antithrombotic therapy in heart valve diseases pre- and postoperative]. Bruhn HD Internist (Berl); 1998 Dec; 39(12):1296. PubMed ID: 10198837 [No Abstract] [Full Text] [Related]
17. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability. Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196 [TBL] [Abstract][Full Text] [Related]
18. New oral antithrombotics: a need for laboratory monitoring. For. Mismetti P; Laporte S J Thromb Haemost; 2010 Apr; 8(4):621-6. PubMed ID: 20102486 [No Abstract] [Full Text] [Related]